Latest News

November 30, 2011
A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa.
November 07, 2011
Low level HIV viremia – the presence of HIV in the bloodstream at levels undetectable by standard tests – was not associated with increased blood markers of inflammation or coagulation, or with increased risk of death, in adults taking highly active anti-retroviral therapy (HAART) for HIV infection, in a study led by researchers at the San Francisco VA Medical Center and UCSF.
October 25, 2011
The U.S. Health Resources and Services Administration has funded the UCSF Center for AIDS Prevention Studies to provide leadership and support to seven states implementing interventions to enhance HIV testing and diagnosis.
July 11, 2011
An international team led by researchers from UCSF and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
December 07, 2010
David Vlahov, PhD, RN, a pioneer in urban health research, expert in global health epidemiology and highly prolific author, has been appointed the new dean of the UCSF School of Nursing, one of the nation’s preeminent graduate schools.
August 17, 2010
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.
July 02, 2010
HIV-infected patients who lost subcutaneous fat as a result of taking first-generation antiretroviral drugs still had strikingly less body fat than non-infected controls five years after switching to newer medications, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
May 19, 2010
Researchers have identified how a normal response to infection, one that usually serves to limit the amount of inflammation, actually contributes to disease progression and viral persistence in HIV-infected patients.
May 12, 2010
Understanding the processes underlying the diminishing life span of HIV patients, even though they are responding well to anti-retroviral therapy, will be the focus of a daylong symposium on May 18.

Pages